Bioparox is banned in Russia. Why the spray was banned and discontinued in Europe and other countries. The company's position and existing drugs analogues

In April 2016, Roszdravnadzor brought to the attention of citizens and all entities responsible for the distribution of drugs that the company's Laboratory Servier (France) withdrew permission to use the drug Bioparox aerosol for inhalation dosed (active ingredient: fusafungin) and the registration certificate for this medication has been terminated. That is, legal sale and use in the treatment of this drug from the date on the territory of Russia is prohibited.

It should be noted that in the European Union countries, the Committee for Risk Assessment in Pharmacology has recognized the negligible use of this drug for the treatment of rhinitis, pharyngitis, laryngitis, tracheitis, angina or sinusitis caused by infectious agents,compared with the risk of developing allergic and anaphylactic problems that are rare, but could have occurred in patients taking this drug. And this was done earlier than ours, but now the wave of prohibition has reached Russia.

So the use of Bioparox is unsafe, and the local use of antibiotics and similar means is still more like pumping money from gullible citizens. In my experience I noticed that antibiotics added to various candies, sprays or aerosols do not give any significant effect in the treatment of infectious diseases of the larynx or pharynx and serve only for self-complacency of patients. Also, no one has presented the evidence base for the effective use of these funds, and most likely will not present them. She's not here. But the other drugs either do not pose a threat to the health of patients and are still allowed to be used in Russia, or they have not yet reached the forbidden measures after assessing the benefit-risk relationship from their use. So the abolition of the use of these funds, it seems to me, is just around the corner.

It is worth noting the decency of the French manufacturer of Bioparox, because the revocation of this license and the right to use the drug company Servier produced independently, and not after the ban initiated by Roszdravnadzor. That is, they saw the problem and they themselves eliminated it. This can be taken into account as a plus for the manufacturer and its ethics in relation to consumers of their medicines. Here is the official position of the manufacturer Bioparox:

Direct analogues of Bioparox at the moment does not exist, because the active substance fusafungin is the development of a French laboratory and no one has used this substance in its preparations. So, as an alternative, you can offer a wide range of antibiotics used orally or in injectable form (as it is supposed, and not to simulate the fight against infections),plus various antiseptics in the form of sprays, lozenges, aerosols that can be applied topically or to lubricate the inflamed areas of the mouth and throat, plus symptomatic therapy. And the history of the aerosol Bioparox at this stage is closed.